Special Interview COVID-19
CDTRP’s TREAT-COVID study has now open site recruitment in 10 of 11 transplant sites, which aims to recruit 2590 organ and stem cell transplant patients, along with 2590 of family members or caregivers. Learn more about the study here: https://cdtrp.ca/en/treatcovid/#toc_Recruitment.
Join Michelle Burleigh (Co-Chair of the Canadian Immunocompromised Advocacy Network, cancer survivor), Dr. Jia Hu (19 to Zero CEO, public health physician), and TREAT-COVID PFD Research co-leads, Rienk de Vries and Sherrie Logan for a conversation of how research can inform policy and how immunocompromised individuals continue to be affected by COVID-19 and other respiratory diseases.